INFANRIX-IPV/HIB
INFANRIX-IPV/HIB
Dormant
DIN Number
02257122
Drug Class
Human
Market Date
Oct 25, 2012
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02257122
AIG Number0950281002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07CA06 DIPHT-HEMOPH INFLUEN B-PERTUSS-POLIO-TETANUS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (9)
DIPHTHERIA TOXOIDActive
Strength: 30 UNIT / 0.5 ML
Monograph: DIPHTHERIA TOXOID
FILAMENTOUS HAEMAGGLUTININActive
Strength: 25 MCG / 0.5 ML
Monograph: FILAMENTOUS HAEMAGGLUTININ
HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE (PRP-T)Active
Strength: 10 MCG / 0.5 ML
Monograph: HAEMOPHILUS INFLUENZAE TYPE B-PRP AND TETANUS TOXOID CONJUGATE (PRP-T)
INACTIVATED POLIOVIRUS TYPE IActive
Strength: 40 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE I
INACTIVATED POLIOVIRUS TYPE IIActive
Strength: 8 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE II
INACTIVATED POLIOVIRUS TYPE IIIActive
Strength: 32 UNIT / 0.5 ML
Monograph: INACTIVATED POLIOVIRUS TYPE III
PERTACTINActive
Strength: 8 MCG / 0.5 ML
Monograph: PERTACTIN
PERTUSSIS TOXOIDActive
Strength: 25 MCG / 0.5 ML
Monograph: PERTUSSIS TOXOID
TETANUS TOXOIDActive
Strength: 40 UNIT / 0.5 ML
Monograph: TETANUS TOXOID